Phillip L. Evans

Synthesis, Structure−Activity Relationships, and Pharmacokinetic Properties of Dihydroorotate Dehydrogenase Inhibitors:  2-Cyano-3-cyclopropyl-3-hydroxy- <i>N</i>-[3‘-methyl-4‘-(trifluoromethyl)phenyl]propenamide and Related Compounds

Elizabeth Kuo, P. Hambleton, David P. Kay et al. · Journal of Medicinal Chemistry · 1996 · 90 citations · Full text

Pharmaceutical Science, Pyrimidine Biosynthesis, Pharmacotherapy +19

Stereochemistry of intermediates in homogeneous hydrogenation catalysed by tristriphenylphosphinerhodium chloride, employing nuclear magnetic resonance magnetisation transfer

John M. Brown, Phillip L. Evans, Andrew R. Lucy · Journal of the Chemical Society Perkin Transactions 2 · 1987 · 48 citations

Rapid Exchange, Engineering, Homogeneous Hydrogenation +17

Phosphinosulphoxide rhodium complexes. Synthesis, crystal structure, and catalytic chemistry of [(2,3,5,6-η)-bicyclo[2.2.1]-hepta-2,5-diene][P,O-diphenyl(phenylsulphinylmethyl)-phosphine]rhodium(I) trifluoromethanesulphonate and asymmetric analogues

Nathaniel W. Alcock, John M. Brown, Phillip L. Evans · Journal of Organometallic Chemistry · 1988 · 39 citations

Inorganic Chemistry, Chemical Engineering, Phosphinosulphoxide Rhodium Complexes +8

The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.

Michael D. Mullican, David Lauffer, Roger J. Gillespie et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 26 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +5